Abstract
Patients are increasingly able to conceive and develop sophisticated medical devices and services to meet their own needs - often without any help from companies that produce or sell medical products. This “free” patient-driven innovation process enables them to benefit from important advances that are not commercially available. Patient innovation also can provide benefits to companies that produce and sell medical devices and services. In this article, we look at two examples of free innovation in the medical field - one for managing type 1 diabetes and the other for managing Crohn’s disease. We will set these cases within the context of the broader free innovation movement that has been gaining momentum in an array of industries and apply the general lessons of free innovation to the specific circumstances of medical innovation by patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gambardella, A., Raasch, C., and von Hippel, E. “The User Innovation Paradigm: Impacts on Markets and Welfare,” Management Science 63, no. 5 (May 2017): 1,450-1,468.
von Hippel, E. Free Innovation (Cambridge, Massachusetts: MIT Press, 2016).
de Jong, J., von Hippel, E., Gault, F., Kuusisto, J., and Raasch, C. “Market Failure in the Diffusion of Consumer- Developed Innovations: Patterns in Finland,” Research Policy 44, no.10 (December 2015): 1,856-1,865.
Lewis, D.M. “Opening Up to Patient Innovation,” NEJM Catalyst, July 12, 2018.
Makower, J., Meer, A., and Denend, L. “Food and Drug Administration’s Impact on U.S. Medical Technology Innovation: A Survey of Over 200 Medical Technology Companies” (Washington, D.C.: Advanced Medical Technology Association, Nov. 15, 2010).
Seaquist, E.R., Anderson, J., Childs, B., Cryer, P., et al. “Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society,” Diabetes Care 36, no. 5 (May 2013): 1,384-1,395.
Torrance, A.W. and von Hippel, E. “The Right to Innovate,” Michigan State Law Review, no. 2 (2015): 793-82
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Fachmedien Wiesbaden GmbH, part of Springer Nature
About this chapter
Cite this chapter
Demonaco, H., Oliveira, P., Torrance, A., von Hippel, C., von Hippel, E. (2020). When patients become innovators. In: Tiwari, R., Buse, S. (eds) Managing Innovation in a Global and Digital World. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-27241-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-658-27241-8_9
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-27240-1
Online ISBN: 978-3-658-27241-8
eBook Packages: Business and ManagementBusiness and Management (R0)